Back to Search Start Over

Roche Climbs As Once-Daily Weight Loss Pill Shows Promise.

Authors :
Hart, Robert
Source :
Forbes.com; 7/17/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

Patients taking Roche's experimental drug, in the same class as injectables like Ozempic, Wegovy, Mounjaro and Zepbound, lost an average of 6% of their starting bodyweight after a month. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
WEIGHT loss
PILLS
SEMAGLUTIDE
EX-smokers

Details

Language :
English
Database :
Complementary Index
Journal :
Forbes.com
Publication Type :
Periodical
Accession number :
178477287

Tools

Authors Abstract Subjects Details